These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18440763)

  • 1. [Genetic polymorphisms and opioid therapies].
    Landau R
    Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current evidence for a genetic modulation of the response to analgesics.
    Lötsch J; Geisslinger G
    Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors in pain and its treatment.
    Stamer UM; Stüber F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain and genetics.
    Fernandez Robles CR; Degnan M; Candiotti KA
    Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain polymorphisms and opioids: An evidence based review.
    Vieira CMP; Fragoso RM; Pereira D; Medeiros R
    Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic variation-- important for the clinical effect of opioids?].
    Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
    Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
    Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacogenetics of opioid treatment for pain management.
    Singh A; Zai C; Mohiuddin AG; Kennedy JL
    J Psychopharmacol; 2020 Nov; 34(11):1200-1209. PubMed ID: 32715846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
    Adegbola MA
    Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in the COMT gene: implications for pain perception and pain treatment.
    Andersen S; Skorpen F
    Pharmacogenomics; 2009 Apr; 10(4):669-84. PubMed ID: 19374521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the genetic determinants of pain and pain management.
    Miaskowski C
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.
    Mogil JS; Ritchie J; Smith SB; Strasburg K; Kaplan L; Wallace MR; Romberg RR; Bijl H; Sarton EY; Fillingim RB; Dahan A
    J Med Genet; 2005 Jul; 42(7):583-7. PubMed ID: 15994880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.
    Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A
    Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of opioid pharmacogenetics.
    Argoff CE
    Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.
    Saiz-Rodríguez M; Ochoa D; Herrador C; Belmonte C; Román M; Alday E; Koller D; Zubiaur P; Mejía G; Hernández-Martínez M; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):321-329. PubMed ID: 30281924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.